Balaji Amines Ltd management interview: Balaji Amines Targets ₹1,800 Crore Revenue In FY27, Maintains 22-24% EBITDA Margin Guidance | ET Now
ET Now, 2026-11-03. Video: https://www.youtube.com/watch?v=cWGRSR7xHk0
- FY25 guidance: Management expects topline of 1,700 to 1,800 crore and EBITDA margins of 22 to 24%; it said margins were 25% for the half year ending and 22, 23% for the quarter.
- Capacity ramp-up: Acetonitrile capacity of about 1,440 metric tonnes per month commenced last month, with production expected to come on stream around this quarter end; it could contribute 50 to 100 crore in the next coming 2 quarters. N-Methylmorpholine, EDA derivatives, sodium cyanide, hydrogen cyanide and related derivatives are expected to ramp up around the end of this financial year or the first quarter of the next financial year.
- FY26 ambition: For 2025 and 26, management aims for minimum 3,500 to 4,000 crores topline with 22% EBITDA margins.
- Logistics and input costs: West Asia-related freight disruption is continuing; exports were down almost 6 to 7% on a half-yearly year-on-year basis, and customers are waiting for freight rates to normalise. Raw-material price volatility remains, limiting buying decisions, though the company said it is passing costs on to customers.
- DME exports: Some PESO approvals are complete and domestic approvals are pending; international approvals have enabled exports of 4 to 5 ISO tanks. Management sees opportunity in overseas and domestic aerosol markets once PESO approval is complete.